Home Cart Sign in  
Chemical Structure| 83730-53-4 Chemical Structure| 83730-53-4

Structure of BSO
CAS No.: 83730-53-4

Chemical Structure| 83730-53-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

L-Buthionine Sulfoximine is a potent inhibitor of GSH synthesis.

Synonyms: L-BSO; NSC 326231; L-Buthionine sulfoximine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BSO

CAS No. :83730-53-4
Formula : C8H18N2O3S
M.W : 222.31
SMILES Code : N[C@@H](CCS(CCCC)(=O)=N)C(O)=O
Synonyms :
L-BSO; NSC 326231; L-Buthionine sulfoximine
MDL No. :MFCD00067000
InChI Key :KJQFBVYMGADDTQ-CVSPRKDYSA-N
Pubchem ID :119565

Safety of BSO

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
cardiomyocytes 30 μM 2 h To assess the effect of the oxidative stress inducer menadione on cardiomyocyte contractile function, results showed that menadione significantly decreased cardiomyocyte contractile function, while the antioxidant NAC and ER stress inhibitor TUDCA reversed this effect. PMC2703679
RAW264.7 cells 0.5 mM overnight Investigate the effect of BSO on NF-κB inhibition PMC8406555
transformed astrocytes 10 µM 24 h To assess the effect of glutathione depletion on cell number, results showed that male cells were more sensitive to glutathione depletion. PMC9669217

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice MBCUCP1 KO mice Intraperitoneal injection 0.445 mg/g/d 5 weeks BSO treatment significantly reduced serum glutathione levels and attenuated insulin tolerance PMC11145561
Mice MLL-AF9 AML model i.p. and in drinking water 2.23 mg/kg + 4.45 mg/ml twice daily for 4 days BSO treatment did not significantly improve the survival of AML-bearing mice PMC8397232
Mice C57BL/6 mice Intraperitoneal injection 100 mg/kg Single dose, 2 hours duration BSO treatment increased mitochondrial content in LSK and HSC populations, mimicking LPS and S. typhimurium-induced ROS elevation. PMC6900710
Mice GSH-depleted model Intraperitoneal injection 650 mg/kg Single dose, lasting 24 hours To evaluate the effect of BSO on psoralen and isopsoralen-induced hepatotoxicity, results showed that BSO significantly enhanced the hepatotoxicity of psoralen PMC6151710
BALB/c nu/nu athymic mice HCC827 cell-derived xenograft model Intraperitoneal injection 450 mg/kg Every 2 days, until the end of the experiments Investigated the effect of BSO on ALDH1A1-induced erlotinib resistance, finding that BSO could reverse ALDH1A1-induced erlotinib resistance. PMC6831290
mice FVB and MT overexpression transgenic mice drinking water 30 mM 2 weeks To evaluate the effects of BSO on cardiac function, oxidative stress, ER stress, and myocardial ultrastructure, results showed that BSO significantly reduced cardiac function, increased oxidative stress and ER stress, and caused changes in myocardial ultrastructure, while MT overexpression reversed these effects. PMC2703679

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.50mL

0.90mL

0.45mL

22.49mL

4.50mL

2.25mL

44.98mL

9.00mL

4.50mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories